Sheshbaradaran, Hooshmand,Berger, Walter,Heffeter, Petra
申请号：
AU2011279836
公开号：
AU2011279836A1
申请日:
2011.07.18
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
A combination therapy is disclosed for treating cancer. The method comprises administering to a cancer patient a therapeutically effective amount of trans-[tetrachlorobis(1H-indazole)ruthenate(III)] or a pharmaceutically acceptable salt thereof, and administering to the patient a therapeutically effective amount of one or more other anti-cancer agents as disclosed herein.
